Skip to main content
Century Therapeutics, Inc. (IPSC)
NASDAQ: IPSC · Real-Time Price · USD
2.560
+0.130 (5.35%)
Mar 5, 2026, 4:00 PM EST - Market closed

Century Therapeutics Revenue

Century Therapeutics had revenue of $113.34M in the twelve months ending September 30, 2025, up 4,122.69% year-over-year. In the year 2024, Century Therapeutics had annual revenue of $6.59M with 194.81% growth.

Revenue (ttm)
$113.34M
Revenue Growth
+4,122.69%
P/S Ratio
4.06
Revenue / Employee
$755,580
Employees
150
Market Cap
459.90M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20246.59M4.35M194.81%
Dec 31, 20232.24M-2.96M-57.01%
Dec 31, 20225.20M--
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Vanda Pharmaceuticals 216.11M
REGENXBIO 170.44M
Lineage Cell Therapeutics 10.82M
4D Molecular Therapeutics 120.00K
Lyell Immunopharma 41.00K
Altimmune 41.00K
vTv Therapeutics 17.00K
Revenue Rankings

IPSC News

More News